Literature DB >> 32759192

Association of education with Aβ burden in preclinical familial and sporadic Alzheimer disease.

Julie Gonneaud1, Christophe Bedetti2, Alexa Pichet Binette2, Tammie L S Benzinger2, John C Morris2, Randall J Bateman2, Judes Poirier2, John C S Breitner2, Sylvia Villeneuve1.   

Abstract

OBJECTIVE: To determine whether years of education and the ε4 risk allele at APOE influence β-amyloid (Aβ) pathology similarly in asymptomatic individuals with a family history of sporadic Alzheimer disease (AD) and presymptomatic autosomal dominant AD mutation carriers.
METHODS: We analyzed cross-sectional data from 106 asymptomatic individuals with a parental history of sporadic AD (PREVENT-AD cohort; age 67.28 ± 4.72 years) and 117 presymptomatic autosomal dominant AD mutation carriers (DIAN cohort; age 35.04 ± 9.43 years). All participants underwent structural MRI and Aβ-PET imaging. In each cohort we investigated the influence of years of education, APOE ε4 status, and their interaction on Aβ-PET.
RESULTS: Asymptomatic individuals with a parental history of sporadic AD showed increased Aβ burden associated with APOE ε4 carriage and lower level of education, but no interaction between these. Presymptomatic mutation carriers of autosomal dominant AD showed no relation between APOE ε4 and Aβ burden, but increasing level of education was associated with reduced Aβ burden. The association between educational attainment and Aβ burden was similar in the 2 cohorts.
CONCLUSIONS: While the APOE ε4 allele confers increased tendency toward Aβ accumulation in sporadic AD only, protective environmental factors, like increased education, may promote brain resistance against Aβ pathology in both sporadic and autosomal dominant AD.
© 2020 American Academy of Neurology.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32759192      PMCID: PMC7713743          DOI: 10.1212/WNL.0000000000010314

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  49 in total

1.  Effects of education on aging-related cortical thinning among cognitively normal individuals.

Authors:  Jun Pyo Kim; Sang Won Seo; Hee Young Shin; Byoung Seok Ye; Jin-Ju Yang; Changsoo Kim; Mira Kang; Seun Jeon; Hee Jin Kim; Hanna Cho; Jung-Hyun Kim; Jong-Min Lee; Sung Tae Kim; Duk L Na; Eliseo Guallar
Journal:  Neurology       Date:  2015-07-31       Impact factor: 9.910

2.  Relationship between physical activity, cognition, and Alzheimer pathology in autosomal dominant Alzheimer's disease.

Authors:  Stephan Müller; Oliver Preische; Hamid R Sohrabi; Susanne Gräber; Mathias Jucker; John M Ringman; Ralph N Martins; Eric McDade; Peter R Schofield; Bernardino Ghetti; Martin Rossor; Nick N Fox; Neill R Graff-Radford; Johannes Levin; Adrian Danek; Jonathan Vöglein; Stephen Salloway; Chengjie Xiong; Tammie Benzinger; Virginia Buckles; Colin L Masters; Reisa Sperling; Randall J Bateman; John C Morris; Christoph Laske
Journal:  Alzheimers Dement       Date:  2018-09-25       Impact factor: 21.566

Review 3.  Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis.

Authors:  Davis C Ryman; Natalia Acosta-Baena; Paul S Aisen; Thomas Bird; Adrian Danek; Nick C Fox; Alison Goate; Peter Frommelt; Bernardino Ghetti; Jessica B S Langbaum; Francisco Lopera; Ralph Martins; Colin L Masters; Richard P Mayeux; Eric McDade; Sonia Moreno; Eric M Reiman; John M Ringman; Steve Salloway; Peter R Schofield; Reisa Sperling; Pierre N Tariot; Chengjie Xiong; John C Morris; Randall J Bateman
Journal:  Neurology       Date:  2014-06-13       Impact factor: 9.910

4.  Exercise Engagement as a Moderator of the Effects of APOE Genotype on Amyloid Deposition.

Authors:  Denise Head; Julie M Bugg; Alison M Goate; Anne M Fagan; Mark A Mintun; Tammie Benzinger; David M Holtzman; John C Morris
Journal:  Arch Neurol       Date:  2012-05

5.  Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease.

Authors:  Anne M Fagan; Chengjie Xiong; Mateusz S Jasielec; Randall J Bateman; Alison M Goate; Tammie L S Benzinger; Bernardino Ghetti; Ralph N Martins; Colin L Masters; Richard Mayeux; John M Ringman; Martin N Rossor; Stephen Salloway; Peter R Schofield; Reisa A Sperling; Daniel Marcus; Nigel J Cairns; Virginia D Buckles; Jack H Ladenson; John C Morris; David M Holtzman
Journal:  Sci Transl Med       Date:  2014-03-05       Impact factor: 17.956

6.  Proximity to Parental Symptom Onset and Amyloid-β Burden in Sporadic Alzheimer Disease.

Authors:  Sylvia Villeneuve; Jacob W Vogel; Julie Gonneaud; Alexa Pichet Binette; Pedro Rosa-Neto; Serge Gauthier; Randall J Bateman; Anne M Fagan; John C Morris; Tammie L S Benzinger; Sterling C Johnson; John C S Breitner; Judes Poirier
Journal:  JAMA Neurol       Date:  2018-05-01       Impact factor: 18.302

7.  Clinical and biomarker changes in dominantly inherited Alzheimer's disease.

Authors:  Randall J Bateman; Chengjie Xiong; Tammie L S Benzinger; Anne M Fagan; Alison Goate; Nick C Fox; Daniel S Marcus; Nigel J Cairns; Xianyun Xie; Tyler M Blazey; David M Holtzman; Anna Santacruz; Virginia Buckles; Angela Oliver; Krista Moulder; Paul S Aisen; Bernardino Ghetti; William E Klunk; Eric McDade; Ralph N Martins; Colin L Masters; Richard Mayeux; John M Ringman; Martin N Rossor; Peter R Schofield; Reisa A Sperling; Stephen Salloway; John C Morris
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

8.  Data-driven models of dominantly-inherited Alzheimer's disease progression.

Authors:  Neil P Oxtoby; Alexandra L Young; David M Cash; Tammie L S Benzinger; Anne M Fagan; John C Morris; Randall J Bateman; Nick C Fox; Jonathan M Schott; Daniel C Alexander
Journal:  Brain       Date:  2018-05-01       Impact factor: 13.501

9.  Brain properties predict proximity to symptom onset in sporadic Alzheimer's disease.

Authors:  Jacob W Vogel; Etienne Vachon-Presseau; Alexa Pichet Binette; Angela Tam; Pierre Orban; Renaud La Joie; Mélissa Savard; Cynthia Picard; Judes Poirier; Pierre Bellec; John C S Breitner; Sylvia Villeneuve
Journal:  Brain       Date:  2018-06-01       Impact factor: 15.255

10.  PET staging of amyloidosis using striatum.

Authors:  Bernard J Hanseeuw; Rebecca A Betensky; Elizabeth C Mormino; Aaron P Schultz; Jorge Sepulcre; John A Becker; Heidi I L Jacobs; Rachel F Buckley; Molly R LaPoint; Patrizia Vannini; Nancy J Donovan; Jasmeer P Chhatwal; Gad A Marshall; Kathryn V Papp; Rebecca E Amariglio; Dorene M Rentz; Reisa A Sperling; Keith A Johnson
Journal:  Alzheimers Dement       Date:  2018-05-21       Impact factor: 21.566

View more
  3 in total

1.  Differentiating amyloid beta spread in autosomal dominant and sporadic Alzheimer's disease.

Authors:  Elizabeth Levitis; Jacob W Vogel; Thomas Funck; Vladimir Hachinski; Serge Gauthier; Jonathan Vöglein; Johannes Levin; Brian A Gordon; Tammie Benzinger; Yasser Iturria-Medina; Alan C Evans
Journal:  Brain Commun       Date:  2022-04-13

2.  Accelerated functional brain aging in pre-clinical familial Alzheimer's disease.

Authors:  Etienne Vachon-Presseau; Sylvia Villeneuve; Julie Gonneaud; Alex T Baria; Alexa Pichet Binette; Brian A Gordon; Jasmeer P Chhatwal; Carlos Cruchaga; Mathias Jucker; Johannes Levin; Stephen Salloway; Martin Farlow; Serge Gauthier; Tammie L S Benzinger; John C Morris; Randall J Bateman; John C S Breitner; Judes Poirier
Journal:  Nat Commun       Date:  2021-09-09       Impact factor: 17.694

3.  The APOE ε4 Allele Affects Cognitive Functions Differently in Carriers of APP Mutations Compared to Carriers of PSEN1 Mutations in Autosomal-Dominant Alzheimer's Disease.

Authors:  Ove Almkvist; Caroline Graff
Journal:  Genes (Basel)       Date:  2021-12-07       Impact factor: 4.096

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.